Cambridge Innovation Capital
VC · Cambridge · United Kingdom
Stages
Investment region
Industries
Profile
Cambridge Innovation Capital is a venture capital firm based in Cambridge, United Kingdom, founded in 2013. The firm focuses on investing in life sciences and deep technology sectors, leveraging its structured access to Cambridge's intellectual property and academic resources. The team comprises 10 professionals who bring a wealth of experience in venture capital and technology investments. The firm invests in sectors such as artificial intelligence, quantum technologies, semiconductors, robotics, autonomous systems, therapeutics, medtech, diagnostics, digital health, and genomics & proteomics. Cambridge Innovation Capital typically invests in Seed and Series A stages, focusing on companies across the United Kingdom. The firm is actively seeking new investments and is a member of the British Venture Capital Association and Principles for Responsible Investment. Notable investments include TRIMTECH Therapeutics - drug discovery, Trent AI - network management software, Immutrin - drug discovery, BeyondMath - business/productivity software, and Nuclera - healthcare technology systems. The firm has a portfolio of 27 companies and has achieved 20 exits.
Contacts (2)
| Name | Title | Phone | ||
|---|---|---|---|---|
| Managing Partner | — | — | — | |
| Partner and CFO | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.